Expression of type-1 plasminogen activator inhibitor in the kidney of diabetic rat models

Thrombosis Research

Volumn 111, Issue 4-5, 2003, Pages 301-309

  Hagiwara, Hiromi ^a   Kaizu, Kazo ^b   Uriu, Kohei ^b   Noguchi, Toshinori ^a   Takagi, Ichiro ^b   Qie, Yue Ling ^b   Seki, Taiichiro ^a   Ariga, Toyohiko ^a  

^a NIHON UNIVERSITY   (Japan)

^b UNIVERSITY OF OCCUPATIONAL AND ENVIRONMENTAL HEALTH   (Japan)

Author keywords

Diabetes; Renal gene expression; Tissue type plasminogen activator; Type 1 plasminogen activator inhibitor; Urokinase type plasminogen activator

Indexed keywords

INSULIN; MESSENGER RNA; PLASMINOGEN ACTIVATOR INHIBITOR 1; STREPTOZOCIN; TISSUE PLASMINOGEN ACTIVATOR; UROKINASE;

ANIMAL CELL; ANIMAL TISSUE; ARTICLE; CONTROLLED STUDY; DIABETIC NEUROPATHY; DOWN REGULATION; DRUG EFFECT; GENE EXPRESSION; GLOMERULUS EPITHELIUM; INSULIN DEPENDENT DIABETES MELLITUS; INSULIN TREATMENT; KIDNEY; KIDNEY TUBULE EPITHELIUM; MALE; NON INSULIN DEPENDENT DIABETES MELLITUS; NONHUMAN; PATHOPHYSIOLOGY; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN FUNCTION; PROTEIN LOCALIZATION; RAT; RAT STRAIN; REAL TIME POLYMERASE CHAIN REACTION; STATISTICAL SIGNIFICANCE; STREPTOZOCIN DIABETES; TISSUE DISTRIBUTION; UPREGULATION;

EID: 0347063983     PISSN: 00493848     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.thromres.2003.09.023     Document Type: Article

References (42)

1. Mauer S.M. Structural-functional correlations of diabetic nephropathy. Kidney Int. 45:1994;612-622.
2. Ziyadeh F.N. The extracellular matrix in diabetic nephropathy. Am. J. Kidney Dis. 22:1993;736-744.
3. Adler S. Structure-function relationships associated with extracellular matrix alterations in diabetic glomerulopathy. J. Am. Soc. Nephrol. 5:1994;1165-1172.
4. Lane P.H., Steffes M.W., Mauer S.M. Renal histologic changes in diabetes mellitus. Semin. Nephrol. 10:1990;254-259.
5. Osterby R., Parving H.H., Nyberg G., Hommel E., Jorgensen H.E., Lokkegaard H.et al. A strong correlation between glomerular filtration rate and filtration surface in diabetic nephropathy. Diabetologia. 31:1988;265-270.
6. Kaizu K., Uriu K., Hashimoto O., Eto S. Recent advance in the treatment of diabetic nephropathy: anticoagulant therapy. J. Diabetes Complications. 5:1991;92-94.
7. Vassalli J.D., Sappino A.P., Belin D. The plasminogen activator/plasmin system. J. Clin. Invest. 88:1991;1067-1072.
8. Lacave R., Rondeau E., Ochi S., Delarue F., Schleuning W.D., Sraer J.D. Characterization of a plasminogen activator and its inhibitor in human mesangial cells. Kidney Int. 35:1989;806-811.
9. Fisher E.J., McLennan S.V., Yue D.K., Turtle J.R. High glucose reduces generation of plasmin activity by mesangial cells. Microvasc. Res. 53:1997;173-178.
10. Baricos W.H., Cortez S.L., el-Dahr S.S., Schnaper H.W. ECM degradation by cultured human mesangial cells is mediated by a PA/plasmin/MMP-2 cascade. Kidney Int. 47:1995;1039-1047.
11. Kawano K., Hirashima T., Mori S., Saitoh Y., Kurosumi M., Natori T. Spontaneous long-term hyperglycemic rat with diabetic complications. Otsuka Long-Evans Tokushima Fatty (OLETF) strain. Diabetes. 41:1992;1422-1428.
12. Fukuzawa Y., Watanabe Y., Inaguma D., Hotta N. Evaluation of glomerular lesion and abnormal urinary findings in OLETF rats resulting from a long-term diabetic state. J. Lab. Clin. Med. 128:1996;568-578.
13. Chomczynski P., Sacchi N. Single-step method of RNA isolation by acid guanidinium thiocyanate-phenol-chloroform extraction. Anal. Biochem. 162:1987;156-159.
14. Puissant C., Houdebin L.M. An improvement of the single-step method of RNA isolation by acid guanidinium thiocyanate-phenol-chloroform extraction. BioTechniques. 8:1990;148-149.
15. Zeheb R., Gelehrter T.D. Cloning and sequencing of cDNA for the rat plasminogen activator inhibitor-1. Gene. 73:1988;459-468.
16. Seki T., Healy A.M., Fletcher D.S., Noguchi T., Gelehrter T.D. IL-1beta mediates induction of hepatic type 1 plasminogen activator inhibitor in response to local tissue injury. Am. J. Physiol. 277:1999;G801-G809.
17. Juhan-Vague I., Alessi M.C., Vague P. Increased plasma plasminogen activator inhibitor 1 levels. A possible link between insulin resistance and atherothrombosis. Diabetologia. 34:1991;457-462.
18. Wiman B., Hamsten A. The fibrinolytic enzyme system and its role in the etiology of thromboembolic disease. Semin. Thromb. Hemost. 16:1990;207-216.
19. Panahloo A., Yudkin J.S. Diminished fibrinolysis in diabetes mellitus and its implication for diabetic vascular disease. J. Cardiovasc. Risk. 4:1997;91-99.
20. Park I.S., Kiyomoto H., Abboud S.L., Abboud H.E. Expression of transforming growth factor-beta and type IV collagen in early streptozotocin-induced diabetes. Diabetes. 46:1997;473-480.
21. Wilson H.M., Reid F.J., Brown P.A., Power D.A., Haites N.E., Booth N.A. Effect of transforming growth factor-beta 1 on the plasminogen activators and plasminogen activator inhibitor-1 in renal glomerular cells. Exp. Nephrol. 1:1993;343-350.
22. Dennler S., Itoh S., Vivien D., ten Dijke P., Huet S., Gauthier J.M. Direct binding of Smad3 and Smad4 to critical TGF beta-inducible elements in the promoter of human plasminogen activator inhibitor-type 1 gene. EMBO J. 17:1998;3091-3100.
23. Niimi M., Sato M., Yokote R., Tada S., Takahara J. Effects of central and peripheral injection of leptin on food intake and on brain Fos expression in the Otsuka Long-Evans Tokushima Fatty rat with hyperleptinaemia. J. Neuroendocrinol. 11:1999;605-611.
24. Wolf G., Chen S., Han D.C., Ziyadeh F.N. Leptin and renal disease. Am. J. Kidney Dis. 39:2002;1-11.
25. Haraguchi M., Border W.A., Huang Y., Noble N.A. t-PA promotes glomerular plasmin generation and matrix degradation in experimental glomerulonephritis. Kidney Int. 59:2001;2146-2155.
26. Sappino A.P., Huarte J., Vassalli J.D., Belin D. Sites of synthesis of urokinase and tissue-type plasminogen activators in the murine kidney. J. Clin. Invest. 87:1991;962-970.
27. Oda T., Jung Y.O., Kim H.S., Cai X., Lopez-Guisa J.M., Ikeda Y.et al. PAI-1 deficiency attenuates the fibrogenic response to ureteral obstruction. Kidney Int. 60:2001;587-596.
28. Moll S., Schifferli J.A., Huarte J., Lemoine R., Vassalli J.D., Sappino A.P. LPS induces major changes in the extracellular proteolytic balance in the murine kidney. Kidney Int. 45:1994;500-508.
29. Eddy A.A. Interstitial fibrosis in hypercholesterolemic rats: role of oxidation, matrix synthesis, and proteolytic cascades. Kidney Int. 53:1998;1182-1189.
30. Duymelinck C., Dauwe S.E., Nouwen E.J., De Broe M.E., Verpooten G.A. Cholesterol feeding accentuates the cyclosporine-induced elevation of renal plasminogen activator inhibitor type 1. Kidney Int. 51:1997;1818-1830.
31. Bader R., Bader H., Grund K.E., Mackensen-Haen S., Christ H., Bohle A. Structure and function of the kidney in diabetic glomerulosclerosis. Correlations between morphological and functional parameters. Pathol. Res. Pract. 167:1980;204-216.
32. Lane P.H., Steffes M.W., Fioretto P., Mauer S.M. Renal interstitial expansion in insulin-dependent diabetes mellitus. Kidney Int. 43:1993;661-667.
33. Taft J.L., Nolan C.J., Yeung S.P., Hewitson T.D., Martin F.I. Clinical and histological correlations of decline in renal function in diabetic patients with proteinuria. Diabetes. 43:1994;1046-1051.
34. Wang Y., Rangan G.K., Tay Y.C., Wang Y., Harris D.C. Induction of monocyte chemoattractant protein-1 by albumin is mediated by nuclear factor kappaB in proximal tubule cells. J. Am. Soc. Nephrol. 10:1999;1204-1213.
35. Zoja C., Donadelli R., Colleoni S., Figliuzz M., Bonazzola S., Morigi M.et al. Protein overload stimulates RANTES production by proximal tubular cells depending on NF-kappa B activation. Kidney Int. 53:1998;1608-1615.
36. Rerolle J.P., Hertig A., Nguyen G., Sraer J.D., Rondeau E.P. Plasminogen activator inhibitor type 1 is a potential target in renal fibrogenesis. Kidney Int. 58:2000;1841-1850.
37. Motojima M., Hosokawa A., Yamato H., Muraki T., Yoshioka T. Uremic toxins of organic anions up-regulate PAI-1 expression by induction of NF-kappa B and free radical in proximal tubular cells. Kidney Int. 63:2003;1671-1680.
38. Phillips A.O., Steadman R. Diabetic nephropathy: the central role of renal proximal tubular cells in tubulointerstitial injury. Histol. Histopathol. 17:2002;247-252.
39. Gilbert R.E., Cox A., Wu L.L., Allen T.J., Hulthen U.L., Jerums G.et al. Expression of transforming growth factor-beta1 and type IV collagen in the renal tubulointerstitium in experimental diabetes: effects of ACE inhibition. Diabetes. 47:1998;414-422.
40. Uehara Y., Hirawa N., Numabe A., Kawabata Y., Nagoshi H., Negoro H.et al. Angiotensin-converting enzyme inhibition delays onset of glucosuria with regression of renal injuries in genetic rat model of non-insulin-dependent diabetes mellitus. J. Cardiovasc. Pharmacol. Ther. 3:1998;327-336.
41. Kagami S., Kuhara T., Okada K., Kuroda Y., Border W.A., Noble N.A. Dual effects of angiotensin II on the plasminogen/plasmin system in rat mesangial cells. Kidney Int. 51:1997;664-671.
42. Eddy A.A. Plasminogen activator inhibitor-1 and the kidney. Am. J. Physiol. 283:2002;F209-F220.